SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant Dallas Parkway (A) LP

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 7,826,361.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 7,826,361.00

Aggregate amount beneficially owned by each reporting person

7,826,361.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

15.9 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 6,857,823 shares of Common Stock, and (ii) 968,538 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant Dallas Parkway (B) LP

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 869,827.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 869,827.00

Aggregate amount beneficially owned by each reporting person

869,827.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

1.8 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 807,115 shares of Common Stock, and (ii) 62,712 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant Dallas Parkway (D) LP

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 1,032,216.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 1,032,216.00

Aggregate amount beneficially owned by each reporting person

1,032,216.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

2.1 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 1,032,216 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant Dallas Parkway (F) LP

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 648,942.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 648,942.00

Aggregate amount beneficially owned by each reporting person

648,942.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

1.3 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 648,942 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant PIF Aggregator A LP

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,199,998.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,199,998.00

Aggregate amount beneficially owned by each reporting person

3,199,998.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

6.5 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 3,199,998 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant GP Holdings LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 10,377,346.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 10,377,346.00

Aggregate amount beneficially owned by each reporting person

10,377,346.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

21.1 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 9,346,096 shares of Common Stock, and (ii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant Capital LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,454,529.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,454,529.00

Aggregate amount beneficially owned by each reporting person

14,454,529.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

29.5 %

Type of Reporting Person (See Instructions)

IA, OO

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 13,423,279 shares of Common Stock, and (ii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Conversant Private GP LLC

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 4,077,183.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 4,077,183.00

Aggregate amount beneficially owned by each reporting person

4,077,183.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

8.3 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 4,077,183 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

CPIF K Co-Invest SPT A, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 224,829.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 224,829.00

Aggregate amount beneficially owned by each reporting person

224,829.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

0.5 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 224,829 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

CPIF Sparti SAF, L.P.

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 652,356.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 652,356.00

Aggregate amount beneficially owned by each reporting person

652,356.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

1.3 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 652,356 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s):

140475203

Name of reporting person

Simanovsky Michael

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

SEC use only

Source of funds (See Instructions)

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,454,529.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,454,529.00

Aggregate amount beneficially owned by each reporting person

14,454,529.00

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in Row (11)

29.5 %

Type of Reporting Person (See Instructions)

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 13,423,279 shares of Common Stock, and (ii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Common Stock, $0.01 par value per share

(b)

Name of Issuer:

SONIDA SENIOR LIVING, INC.

(c)

Address of Issuer's Principal Executive Offices:

14755 PRESTON ROAD, SUITE 810, DALLAS, TEXAS , 75254.

Item 1 Comment:

This Amendment No. 10 ("Amendment No. 10") further amends and supplements the original statement on Schedule 13D filed by Conversant Dallas Parkway (A) LP ("Investor A"), Conversant Dallas Parkway (B) LP ("Investor B"), Conversant GP Holdings LLC ("Conversant GP"), Conversant Capital LLC ("Conversant Capital"), and Michael J. Simanovsky on November 12, 2021 (the "Original Schedule 13D"), as previously amended by them by the amended statement on Schedule 13D filed on August 10, 2026 ("Amendment No. 9"), Amendment No. 8 filed on March 13, 2026, Amendment No. 7 filed on November 5, 2025, Amendment No. 6 filed on October 17, 2024, Amendment No. 5 filed on August 21, 2024, Amendment No. 4 filed on March 26, 2024, Amendment No. 3 filed on February 6, 2024, Amendment No. 2 filed on November 6, 2023 and Amendment No. 1 filed on July 7, 2023. Amendment No. 4 was the initial statement on Schedule 13D for Conversant Dallas Parkway (D) LP ("Investor D") regarding the Issuer. Amendment No. 5 was the initial statement on Schedule 13D for Conversant PIF Aggregator A LP ("Aggregator A"), and Conversant Private GP LLC ("Conversant Private GP") regarding the Issuer. Amendment No. 6 was the initial statement on Schedule 13D for Conversant Dallas Parkway (F) LP ("Investor F") regarding the Issuer. Amendment No. 8 was the initial statement on Schedule 13D for CPIF K Co-Invest SPT A, L.P. ("CPIF K") and CPIF Sparti SAF, L.P. ("CPIF SAF"). Investor A, Investor B, Investor D, Aggregator A, Investor F, CPIF K and CPIF SAF together are the "Conversant Investors," and they, together with Conversant GP, Conversant Capital, Conversant Private GP and Mr. Simanovsky are the "Reporting Persons." The Original Schedule 13D, as previously amended, remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 10, provided that with respect to any Item amended herein, if such Item is incorporated by reference into any other Item in the Original Schedule 13D, as previously amended, such incorporation by reference is also amended hereby. Capitalized terms used and not defined in this Amendment No. 10 have the meanings set forth in the Original Schedule 13D, as previously amended.

Item 3.

Source and Amount of Funds or Other Consideration

Item 3 of the Original Schedule 13D, as previously amended, is hereby amended to incorporate the following. On August 21, 2026, at the request of certain limited partners of CPIF SAF unaffiliated with Conversant Capital, and in satisfaction of Conversant Private GP's pre-existing obligations to such limited partners, Conversant Private GP caused CPIF SAF to distribute in kind an aggregate 1,182,595 shares of Common Stock to such limited partners for no consideration, in connection with their withdrawal from CPIF SAF.

Item 4.

Purpose of Transaction

Item 4 of the Original Schedule 13D, as previously amended, is hereby amended by the addition of the following description of events involving the Reporting Persons and certain limited partners of CPIF SAF. The disclosure set forth in Item 3 above regarding the distribution of shares of Common Stock to certain limited partners in CPIF SAF is incorporated herein.

Item 5.

Interest in Securities of the Issuer

(a)

With respect to each Reporting Person, the information set forth in rows 11 and 13 of the applicable cover page is incorporated herein by reference.

(b)

With respect to each Reporting Person, the information set forth in rows 7-10 of the applicable cover page is incorporated herein by reference.

(c)

Not applicable.

(d)

Except for clients of Conversant Capital or another investment advisor subsidiary of Conversant Capital who may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock or Warrants, if any, held in managed accounts, no person other than the Reporting Persons are known by the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any Common Stock or Warrants described in this Schedule 13D, other than indirect interests of investors in the Conversant Investors.

(e)

Not applicable.

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

Item 6 is hereby amended by the addition of the following. The disclosure set forth in Item 3 above regarding the transfer of shares of Common Stock to certain limited partners in CPIF SAF is incorporated herein. Conversant Capital has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of distributed shares of Common Stock received by, one of the distributees, subject in respect of the latter to an agreed-upon hurdle rate.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Conversant Dallas Parkway (A) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Dallas Parkway (B) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Dallas Parkway (D) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Dallas Parkway (F) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant PIF Aggregator A LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant Private GP LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant GP Holdings LLC

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Capital LLC

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Private GP LLC

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

CPIF K Co-Invest SPT A, L.P.

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant Private GP LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

CPIF Sparti SAF, L.P.

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant Private GP LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Simanovsky Michael

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, Attorney-in-fact for Michael J. Simanovsky
Date:	08/25/2026